Vaneltix Pharma, Inc. — Form D
Vaneltix Pharma, Inc. of NEW BRUNSWICK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-13. The offering totals $15.0M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-04-13
- Form: D
- Accession: 0000932352-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $500K
- Remaining: $14.5M
- Minimum investment: $50K
- Investors: 5
- Date of first sale: 2017-03-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-284723
Issuer
- Name: Vaneltix Pharma, Inc.
- CIK: 0000932352
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 317 GEORGE STREET, NEW BRUNSWICK, NJ, 08901
- Phone: 732-354-3217
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Mark J Rosenblum | Executive Officer | Houston, TX |
| Daniel Vickery | Director | New Brunswick, NJ |
| Daniel Vickery | Executive Officer | New Brunswick, NJ |
| Carlo Lowell Di Fonzo | Director | New Brunswick, NJ |
| C. Lowell Parsons | Director | New Brunswick, NJ |
| Robert Lowell Evans | Director | New Brunswick, NJ |
| Dan Vickery | Director | Bound Brook, NJ |
| Dan Vickery | Executive Officer | Bound Brook, NJ |
| Abe Lowell Hahn | Director | North Brunswick, NJ |
| Michael J Goldberg | Director | North Brunswick, NJ |
| Michael J Nordlicht | Director | North Brunswick, NJ |
| A. Luc Maasdorp | Director | North Brunswick, NJ |
Other filings by this issuer (6)
More